CELLTRION, INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 176,200 KRW | -0.62% |
|
-2.06% | -12.56% |
| May. 24 | Celltrion Receives European Commission Approval of Omlyclo® (CT-P39), the First and Only Omalizumab Biosimilar Approved in Europe | CI |
| May. 10 | Celltrion's Q1 Attributable Profit Slumps 86% | MT |
Quotes 5-day view
End-of-day quote Korea S.E.| 2024-05-27 | 2024-05-28 | 2024-05-29 | 2024-05-30 | 2024-05-31 | |
|---|---|---|---|---|---|
| Last | 179600 ₩ | 180900 ₩ | 178900 ₩ | 177300 ₩ | 176200 ₩ |
| Volume | 401 269 | 411 965 | 493 642 | 357 482 | 882 885 |
| Change | -0.17% | +0.72% | -1.11% | -0.89% | -0.62% |
| Opening | 180,600.00 | 179,600.00 | 179,200.00 | 177,500.00 | 179,700.00 |
| High | 181,200.00 | 182,400.00 | 179,900.00 | 181,400.00 | 182,000.00 |
| Low | 178,500.00 | 178,500.00 | 177,100.00 | 177,200.00 | 176,100.00 |
Performance
| 1 day | -0.62% | ||
| 1 week | -2.06% | ||
| 1 month | -6.77% | ||
| 3 months | -1.95% | ||
| 6 months | +8.03% | ||
| Current year | -12.56% | ||
| 1 year | +0.46% | ||
| 3 years | -31.41% | ||
| 5 years | +5.36% | ||
| 10 years | +386.14% |
Volumes
marketsDaily volume
882 885
Avg. Volume 20 sessions
487 044
Avg. Volume 20 sessions KRW
85 817 152 800.00
Avg. Volume 20 sessions USD
61 959 984.32
Record volume 1
30 681 116
Record volume 2
17 672 300
Record volume 3
17 648 239
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (KRW)
36 316 271 051 247
Capitalization (USD)
26 220 347 699
Net sales (KRW)
2 176
Net sales (USD)
2
Number of employees
2 034
Sales / Employee (KRW)
1
Sales / Employee (USD)
0
Free-Float
66.01 %
Free-Float capitalization (KRW)
25 057 392 794 472
Free-Float capitalization (USD)
18 091 437 598
Average Daily Capital Traded
0.24%
Highs and lows
1 week
176 100.00
182 400.00
1 month
176 100.00197 000.00
Current year
169 700.00241 000.00
1 year
131 000.00241 000.00
3 years
131 000.00283 276.77
5 years
121 026.29372 915.00
10 years
27 751.54372 915.00
Indicators
Moving average 5 days
178 580.00
Moving average 20 days
186 430.00
Moving average 50 days
183 636.00
Moving average 100 days
184 210.00
Price spread / (MMA5)
+1.35%
Price spread / (MMA20)
+5.81%
Price spread / (MMA50)
+4.22%
Price spread / (MMA100)
+4.55%
STIM
RSI 9 days
29.04
RSI 14 days
37.61
Sector Comparison - Other Biotechnology & Medical Research
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| -0.62% | -2.06% | -12.56% | +0.46% | 26.22B | ||
| -5.89% | -14.43% | +43.36% | +10.93% | 54.63B | ||
| -1.51% | -4.58% | -5.31% | +10.11% | 39.92B | ||
| -0.45% | -5.59% | +37.52% | -15.53% | 38.82B | ||
| +0.59% | +1.28% | +14.75% | +50.48% | 26.86B | ||
| -1.07% | +0.45% | -22.45% | -21.33% | 18.78B | ||
| +1.73% | +0.82% | +25.12% | +28.88% | 12.21B | ||
| -0.08% | -4.46% | +0.04% | -5.51% | 12.16B | ||
| +0.17% | -1.08% | +26.04% | +86.74% | 11.94B | ||
| -0.61% | -4.04% | -11.83% | +6.16% | 10.74B | ||
| +1.45% | -1.07% | -3.38% | -8.34% | 9.6B | ||
| -1.82% | -6.48% | +24.38% | -13.99% | 6.71B | ||
| -0.75% | +2.67% | +14.44% | +85.88% | 6.61B | ||
| +0.42% | +1.00% | +33.65% | +52.10% | 6.32B | ||
| -.--% | -.--% | - | - | 6.07B | ||
| +0.19% | -1.78% | -1.89% | -34.55% | 6.03B | ||
| Average | -0.52% | -2.50% | +10.79% | +15.50% | ||
| Weighted average by Cap. | -1.38% | -4.57% | +14.53% | +11.36% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2024 | -12.56% | ||
| 2023 | +25.55% | ||
| 2022 | -15.70% | ||
| 2021 | -43.74% | ||
| 2020 | +102.31% | ||
| 2019 | -14.58% | ||
| 2018 | +2.65% | ||
| 2017 | +109.98% | ||
| 2016 | +33.46% | ||
| 2015 | +124.03% | ||
| 2014 | +6.37% | ||
| 2013 | -24.33% | ||
| 2012 | +24.03% | ||
| 2011 | +8.36% | ||
| 2010 | +123.33% | ||
| 2009 | +51.52% | ||
| 2008 | -16.46% |
- Stock Market
- Equities
- A068270 Stock
- Quotes Celltrion, Inc.
